BridgeBio Pharma, Inc. financial statements
BridgeBio Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 502.08M | 10-K |
| Net income | −USD 724.93M | 10-K |
| Cash and equivalents | USD 570.12M | 10-Q |
| Total debt | USD 2.01B | 10-K |
BridgeBio Pharma, Inc. financials on 6ix · BridgeBio Pharma, Inc. on 6ix